Executive summary: Identification, evaluation, and management of children with autism spectrum disorder

Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics

doi:10.1542/PEDS.2019-3448

Executive summary: Identification, evaluation, and management of children with autism spectrum disorder

Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics

Pediatrics

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Original language	English (US)
Article number	e20193448
Journal	Pediatrics
Volume	145
Issue number	1
DOIs	https://doi.org/10.1542/PEDS.2019-3448
State	Published - Jan 1 2020

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/PEDS.2019-3448

Cite this

@article{ebcfa4f0df1b4048a8aa79865ad67d08,

title = "Executive summary: Identification, evaluation, and management of children with autism spectrum disorder",

author = "{Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics} and Hyman, {Susan L.} and Levy, {Susan E.} and Myers, {Scott M.} and Rodgers, {Anne B.} and Dennis Kuo and Susan Apkon and Davidson, {Lynn F.} and Ellerbeck, {Kathryn A.} and Foster, {Jessica E.A.} and Noritz, {Garey H.} and {O'Connor Leppert}, Mary and Saunders, {Barbara S.} and Christopher Stille and Larry Yin and Timothy Brei and Lipkin, {Paul H.} and Kenneth Norwood and Cara Coleman and Marie Mann and Edwin Simpser and Smith, {Peter J.} and Marshalyn Yeargin-Allsopp and Alex Kuznetsov and Weitzman, {Carol C.} and Childers, {David Omer} and Levine, {Jack M.} and Myriam Peralta-Carcelen and Blum, {Nathan L.} and Takayama, {John Ichiro} and Rebecca Baum and Robert Voigt and Carolyn Bridgemohan and Bauer, {Nerissa S.} and Edward Goldson and Macias, {Michelle M.} and McGuinn, {Laura Joan} and Marilyn Augustyn and Davis, {Beth Ellen} and Alice Meng and High, {Pamela C.} and Carolyn McCarty and Linda Paul",

note = "Funding Information: POTENTIAL CONFLICT OF INTEREST: MeMix LLC is a company that makes an app (for phones). Dr Levy is on the advisory board for the app{\textquoteright}s development. This app is being developed to assist in nutritional and dietary management of children with autism. Dr Levy has not received any money yet from this company. This app is the focus of a National Institutes of Health R21 grant, for which Dr Levy is funded for ∼2% of her salary. Once it is studied and marketed (if appropriate), Dr Levy will (possibly in the future) earn some money. Dr Levy has worked with MeMix LLC from 2015 to the present. Dr Hyman is the site principal investigator of a clinical trial of a novel agent being tested to promote social function in patients with autism. The University of Rochester (Dr Hyman{\textquoteright}s institution) was 1 of .40 sites and had 2 study participants in 2018. University of Rochester will be leaving the trial in 2019 (withdrawal submitted) because of staffing, and that reimbursement for staff time does not cover the cost of participation. Funding was for the staff to complete the assessments required for the clinical trial. Dr Hyman got no personal reimbursement from the company; the funding was for staff time for recruitment and assessment and clinical research center support for the trial. Dr Myers has indicated he has no potential conflicts of interest to disclose.",

year = "2020",

month = jan,

day = "1",

doi = "10.1542/PEDS.2019-3448",

language = "English (US)",

volume = "145",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "1",

}

TY - JOUR

T1 - Executive summary

T2 - Identification, evaluation, and management of children with autism spectrum disorder

AU - Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics

AU - Hyman, Susan L.

AU - Levy, Susan E.

AU - Myers, Scott M.

AU - Rodgers, Anne B.

AU - Kuo, Dennis

AU - Apkon, Susan

AU - Davidson, Lynn F.

AU - Ellerbeck, Kathryn A.

AU - Foster, Jessica E.A.

AU - Noritz, Garey H.

AU - O'Connor Leppert, Mary

AU - Saunders, Barbara S.

AU - Stille, Christopher

AU - Yin, Larry

AU - Brei, Timothy

AU - Lipkin, Paul H.

AU - Norwood, Kenneth

AU - Coleman, Cara

AU - Mann, Marie

AU - Simpser, Edwin

AU - Smith, Peter J.

AU - Yeargin-Allsopp, Marshalyn

AU - Kuznetsov, Alex

AU - Weitzman, Carol C.

AU - Childers, David Omer

AU - Levine, Jack M.

AU - Peralta-Carcelen, Myriam

AU - Blum, Nathan L.

AU - Takayama, John Ichiro

AU - Baum, Rebecca

AU - Voigt, Robert

AU - Bridgemohan, Carolyn

AU - Bauer, Nerissa S.

AU - Goldson, Edward

AU - Macias, Michelle M.

AU - McGuinn, Laura Joan

AU - Augustyn, Marilyn

AU - Davis, Beth Ellen

AU - Meng, Alice

AU - High, Pamela C.

AU - McCarty, Carolyn

AU - Paul, Linda

N1 - Funding Information: POTENTIAL CONFLICT OF INTEREST: MeMix LLC is a company that makes an app (for phones). Dr Levy is on the advisory board for the app’s development. This app is being developed to assist in nutritional and dietary management of children with autism. Dr Levy has not received any money yet from this company. This app is the focus of a National Institutes of Health R21 grant, for which Dr Levy is funded for ∼2% of her salary. Once it is studied and marketed (if appropriate), Dr Levy will (possibly in the future) earn some money. Dr Levy has worked with MeMix LLC from 2015 to the present. Dr Hyman is the site principal investigator of a clinical trial of a novel agent being tested to promote social function in patients with autism. The University of Rochester (Dr Hyman’s institution) was 1 of .40 sites and had 2 study participants in 2018. University of Rochester will be leaving the trial in 2019 (withdrawal submitted) because of staffing, and that reimbursement for staff time does not cover the cost of participation. Funding was for the staff to complete the assessments required for the clinical trial. Dr Hyman got no personal reimbursement from the company; the funding was for staff time for recruitment and assessment and clinical research center support for the trial. Dr Myers has indicated he has no potential conflicts of interest to disclose.

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85077403868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077403868&partnerID=8YFLogxK

U2 - 10.1542/PEDS.2019-3448

DO - 10.1542/PEDS.2019-3448

M3 - Article

C2 - 31843858

AN - SCOPUS:85077403868

SN - 0031-4005

VL - 145

JO - Pediatrics

JF - Pediatrics

IS - 1

M1 - e20193448

ER -

Executive summary: Identification, evaluation, and management of children with autism spectrum disorder

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this